CXC-AG
CXC-AG is a division of CXC, solely focused on developing and commercializing research from top university laboratories. CXC-AG has strong links to McGill University, especially the Smith Lab which is renowned for developing lipochito-oligosaccharides (LCOs), which are arguably the biggest hit in biologicals, in use on hundreds of millions of acres worldwide.
BioFuelNet Canada Inks Research Deal with CXC-AG for 450 Bacterial Strains to Fight GHGs
The new strains have the potential to increase yields in the absence of abiotic stress.
Latest News
ABG Update Feature
The Chemical Briefing: Six Decades On, Chlorpyrifos Still Cheats the Reaper
Six decades after launch, chlorpyrifos defies bans as courts,...
ABG Update Feature
Navigating New Rules: Southeast Asian Countries Tighten Standards for Biologicals and Crop Protection Products
Southeast Asia and India tighten crop protection and biological...
Biologicals
How Seipasa and Valent BioSciences Are Shaping the Next Chapter of Biostimulant Innovation
Seipasa’s partnership with Valent BioSciences accelerates U.S. biostimulant adoption...
ABG Update Feature
Global Agriculture Forecast 2026: Continued Volatility and Needed Adaption Ahead
Here are nine key predictions for global agriculture and...